Dynasore: Practical Guidance for Dynamin GTPase Inhibition in Endocytosis Research

What This Product Solves

Dynasore (CAS No. 304448-55-3, APExBIO SKU A1605) enables selective, reversible inhibition of dynamin family GTPases—including dynamin1, dynamin2, and Drp1. It is routinely used to dissect the mechanistic contribution of dynamin-mediated membrane fission events in endocytosis research. Key applications include blocking transferrin uptake in HeLa cells, probing synaptic vesicle endocytosis inhibition, and manipulating signal transduction pathway study models. Researchers can use Dynasore to temporally control endocytosis and vesicle trafficking, offering a practical approach for mapping dynamin dependency in cellular processes.

For broader context, this article details Dynasore’s utility in clathrin-mediated endocytosis and viral entry studies, while another resource explores actionable workflows and troubleshooting in advanced disease models.

Protocol Parameters

• Solubility (stock preparation) | ≥16.12 mg/mL in DMSO | Required for all in vitro and cell-based assays | Ensures full dissolution; water and ethanol are not recommended solvents due to insolubility | product dossier
• Working concentration | 10–80 µM (typical), with IC50 ≈ 15 µM | Cellular endocytosis assays | Enables dose-dependent, reversible inhibition; start near IC50 for dynamin GTPase inhibition and titrate as needed | product dossier, workflow recommendation
• Stock solution storage | -20°C (short-term only); avoid long-term storage of DMSO solutions | All experimental setups | Maintains compound integrity and prevents degradation; prepare fresh aliquots for consistent results | product dossier
• Stock dissolution aids | Gentle warming to 37°C or ultrasonic shaking | Stock preparation step | Facilitates rapid and complete dissolution in DMSO when preparing concentrated stocks | product dossier

Workflow Setup and QC Checklist

• Compound Handling: Prepare Dynasore stocks in DMSO at concentrations ≥16.12 mg/mL, using gentle warming or ultrasonic agitation to aid dissolution. Avoid aqueous or ethanol solvents.
• Aliquoting: Divide stocks into single-use aliquots before freezing at -20°C. This minimizes freeze-thaw cycles and prevents degradation.
• Working Dilutions: Dilute freshly thawed stock into pre-warmed culture medium immediately before use to achieve the desired assay concentration (commonly 10–80 µM). Keep final DMSO concentration ≤0.1% in cell culture to prevent solvent toxicity.
• Negative Controls: Always include DMSO-only controls to distinguish effects of the inhibitor from vehicle.
• Positive Controls: Where available, use a well-characterized endocytosis inhibitor or a known dynamin GTPase inhibitor as a benchmark.
• Readouts: Assess functional inhibition by measuring transferrin uptake, vesicle trafficking, or other dynamin-dependent endpoints. Include time-course and dose-response data where feasible.
• Documentation: Record lot numbers, storage conditions, and preparation steps for reproducibility.

Common Failure Modes and Fixes

• Incomplete Dissolution: If Dynasore does not fully dissolve in DMSO, repeat gentle warming to 37°C or apply ultrasonic agitation. Do not attempt to dissolve in water or ethanol.
• Loss of Activity: Avoid long-term storage of stock solutions; prepare fresh working solutions for each experiment and store stocks only at -20°C. Discard stocks with repeated freeze-thaw cycles.
• Cell Toxicity: If cytotoxicity is observed, verify the final DMSO concentration and reduce if necessary. Confirm that working concentrations of Dynasore are within the range compatible with your cell type.
• Inconsistent Inhibition: Ensure accurate timing and dosing; titrate concentrations starting from the IC50 (≈15 µM) and adjust based on cell type and assay conditions. Use functional readouts to confirm effective dynamin GTPase inhibition.
• Off-target Effects: Validate findings with orthogonal methods or complementary inhibitors to rule out non-specific effects.

Scope and Limitations

Dynasore is designed for acute, reversible inhibition of dynamin GTPase activity in cellular models. It is suitable for dissecting endocytic and vesicle trafficking processes where rapid, non-genetic manipulation is required. However, it should not be used for chronic inhibition studies, as potential off-target or compensatory effects may confound interpretation. Its insolubility in water and ethanol restricts its use to DMSO-based stock solutions, and careful attention to storage and handling is required to maintain activity. While widely adopted in endocytosis and signal transduction pathway study models, Dynasore's specificity is limited by the inherent properties of small molecule inhibitors and should be verified with appropriate controls.

Conclusion

Dynasore provides researchers with a reliable, reversible means of inhibiting dynamin-dependent endocytosis and vesicle trafficking. With proper handling, dosing, and control design, it facilitates acute manipulation of membrane fission events in cellular and neuronal systems. For researchers seeking a practical tool for dissecting dynamin function, Dynasore (APExBIO A1605) offers reproducibility and workflow compatibility across a range of endocytosis research and signal transduction assays.